Life Sciences Regulation in Finland: Overview

Thomson Reuters Practical Law Life Sciences Global Guide 2023

A Q&A guide to life sciences regulation in Finland.

This Q&A provides a high-level overview of key practical issues, including life sciences clinical trials, manufacturing, marketing, abridged procedure, pharmacovigilance, data privacy, packaging and labelling, biological medicines, medical devices, health care IT, combination products, borderlines, and natural health products.

Read the Finland chapter we contributed: Life Sciences Regulation in Finland: Overview

Read also: Life Sciences Commercialisation in Finland: Overview

More by the same author

First-ever Supreme Administrative Court rulings on GDPR fines – both for and against

The Supreme Administrative Court of Finland has issued its first decisions regarding administrative fines under the General Data Protection Regulation (the “GDPR”). Incidentally, the decisions concerned the first administrative fines imposed by the Finnish Data Protection Ombudsman back in 2020. The court’s essential arguments, as summarised below, may provide useful insights into how the appellate courts will interpret GDPR requirements and, especially, what aspects are key when challenging GDPR fines in the future.

The Finnish National Cyber Security Centre clarifies website cookie practices

Earlier in June, the National Cyber Security Centre of the Finnish Transport and Communications Agency, which supervises the use of cookies in Finland, issued a detailed decision regarding website cookie practices. In its decision, the National Cyber Security Centre assessed the necessity of cookies, the structure of a cookie banner, the standards for the consent mechanism as well as the nature of legitimate interest in connection with cookies. We have compiled the main points of the decision into this D&I Alert.

Life Sciences Commercialisation in Finland: Overview

A Q&A guide to life sciences commercialisation in Finland. This Q&A provides a high-level overview of key practical issues, including the life sciences sector, pricing and state funding, distribution and sale, importing, advertising, patents, trade marks, competition law, and product liability. Read the Finland chapter we contributed: Life Sciences Commercialisation in Finland: Overview Read also:

Latest insights

First-ever Supreme Administrative Court rulings on GDPR fines – both for and against

Alert / 14 Sep 2023
Reading time 2 minutes

Ministry of Finance Proposes Changes to Finnish Transfer Tax Act, Shareholder Loan Receivables Included in the Transfer Tax Base

Article / 22 Aug 2023
Reading time 2 minutes